Skip to main content

Table 1 Patient characteristics regarding initial prostate cancer stage and primary therapy from 43 patients

From: Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer

Variables Value
Primary therapy  
 Radical prostatectomy n (%) 38/43 (88.4%)
 Radiotherapy n (%) 5/43 (11.6%)
Age at primary therapy (years)  
 Mean/SD/median/range 60.3/6.1/60.0/74 - 46
Pathologic Gleason score at primary therapy n (%)  
 6 4/43 (9%)
 7 21/43 (49%)
 8 7/43 (16%)
 9 9/43 (21%)
 x 2/43 (5%)
pT-stage at primary therapy n (%)  
 T2 16/43 (37%)
 T3 26/43 (61%)
 T4 1/43 (2%)
pN-stage at primary therapy n (%)  
 pN0 27/43 (63%)
 pN1 12/43 (28%)
 pNx 4/43 (9%)
Positive surgical margin at primary therapy n (%)  
 R0 17/43 (39%)
 R1 14/43 (33%)
 Rx 12/43 (28%)
Initial PSA at primary therapy (ng/ml)  
 Mean/SD/median/range 16.4/14.83/10.9/4.2 – 24.96
  1. Salvage-LND = Salvage lymph node dissection; SD = Standard deviation.
  2. PSA = Prostate specific antigen (ng/ml).